Van Ermengem E.Ueber einen neuen anaeroben Bacillus und seine Beziehungen zum Botulismus. Z Hyg. 1897;26:1-56. Translated in: Desch S. Rev Infect Dis.1979;1:701-719.
2.
Midura TF, Arnon SSInfant botulism: identification of Clostridium botulinum and its toxin in faeces. Lancet.1976; 2:934-936.
3.
PicketJ., Berg B., Chaplin E., Brunstetter-Shafer MASyndrome of botulism in infancy: clinical and electrophysiologic study . NEngl J Med.1976;295:770-772.
4.
Wilson R., Morris JG, Snyder JD, Feldman RAClinical characteristics of infant botulism in the United States: a study of the non-California cases. Pediatr Infect Dis.1982;1:148-150.
5.
Arnon SS, Damus K., Chin J.Infant botulism: epidemiology and relation to sudden infant death syndrome . Epidemiol Rev.1981;3:45-66.
6.
Arnon SS, Midura TF, Damus K., et al. Intestinal infection and toxin production by Clostridium botulinum as one cause of sudden infant death syndrome. Lancet. 1978;1:1273-1278.
7.
Sonnabend Oar , Sonnabend Wff, Krech U., et al. Continuous microbiological and pathological study of 70 sudden and unexpected infant deaths: toxigenic intestinal Clostridium botulinum infection in 9 cases of sudden infant death syndrome. Lancet. 1985 ; 1:237-241.
8.
Byard RW, Moore L., Bourne AJ, et al. Clostridium botulinum and suddent infant death syndrome: a 10 year prospective study. J Pediatr Child Health. 1992; 28:156-157.
9.
Midura TF, Snowden S., Wood RM, Arnon SSIsolation of Clostridum botulinum from honey. J Clin Microbiol.1979;9:282-283.
10.
Arnon SS, Midura TF, Clay SA, et al. Infant botulism: epidemiological, clinical, and laboratory aspects . JAMA.1977;237:1946-1951.
11.
Oguma K., Yokota K., Hayashi S., et al. Infant botulism due to Clostridum botulinum type C toxin. Lancet.1990;336: 1449-1450.
12.
Aureli P., Fenicia L., Pasolini B., et al. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J Infect Dis.1986;154:207-211.
13.
McCroskey L. , Hatheway C., Fenicia L., et al. Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism. J Clin Microbiol.1986;23:201-202.
14.
Hall J., McCroskey L., Pincomb, B., Hatheway CLIsolation of an organism resembling Clostridium beratiwhich produces type F botulinal toxin from an infant with botulism. J Clin Microbiol.1985;21:654-655.
15.
Hoffman R., Pincomb B., Skeels M., Burkhart MJType F infant botulism. Am J Dis Child.1982 ;136:270-271.
16.
Wilcke B., Midura T., Arnon S.Quantitative evidence of intestinal colonization by Clostridium botulinum in four cases of infant botulism. J Infect Dis.1980; 141:419-423.
17.
Mivazak S., Sakaguchi G.Experimental botulism in chickens: the cecum as the site of production and absorption of botulinal toxin. Jpn J Med Sci Biol. 1978;31:1-15.
18.
Mills DC, Arnon SSThe large intestine as the site of Clostridium botulinum colonization in human infant botulism. J Infect Dis.1987 ;156:997-998.
19.
Simpson LLThe origin, structure and pharmacological activity of botulinum toxin . Pharmacol Rev.1981;33:155-188.
20.
Kao I., Drachman D., Price D.Botulinum toxin: mechanism of presynaptic blockage. Science . 1976;193:1256-1258.
21.
Schreiner MS , Field E., Ruddy R.Infant botulism: a review of 12 years' experience at The Children's Hospital of Philadelphia . Pediatrics.1991;87:159-165.
22.
Spika JS, Shaffner N., Hargrett-Bean N., et al. Risk factors for infant botulism in the United States. Am J Dis Child.1989;143:828-832.
23.
Long SS, Gajewski JL, Brown LW, Gilligan PHClinical, laboratory, and environmental features of infant botulism in Southeastern Pennsylvania. Pediatrics. 1985;75:935-941.
24.
Chia JK, Clark JB, Ryan CA, Pollack M.Botulism in an adult associated with food-borne intestinal infection with Clostridium botulinum. N Engl J Med.1986;315:239-241.
25.
McCroskey LM , Hatheway CLLaboratory findings in adult botulism cases that suggest colonization of the intestinal tract. In: Abstracts of the 86th annual meeting of the American Society for Microbiology . Washington, DC : American Society for Microbiology ; 1986:275. Abstract.
26.
Long SSEpidemiologic study of infant botulism in Pennsylvania: report of the Infant Botulism Study Group. Pediatrics. 1985;75:928-934.
27.
Arnon SS, Damus K., Thompson B., et al. Protective role of human milk against sudden death from infant botulism. J Pediatr.1982;100:568-573.
28.
Thompson JA , Glasgow LA, Warpinski JR, Olson C.Infant botulism: clinical spectrum and epidemiology . Pediatrics.1980;66:936-942.
29.
Yoshioka H. , Iseki K., Fujita K.Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants. Pediatrics.1983; 72: 317-321.
30.
Stark PL, Lee A.Clostridia isolated from the feces of infants during the first year of life . J Pediatr.1982;100:362-365.
31.
Bullen CL, Tearle PV, Stewart MGThe effect of humanized milks and supplemented breast feedings on the faecal flora of infants. J Med Microbiol.1977; 10:403-413.
32.
Long SS, Swenson RMDevelopment of anaerobic fecal flora in healthy newborn infants. J Pediatr.1977;91:298-301.
33.
Mata LJ, Mejicanes ML, Jimenez F.Studies on the indigenous gastrointestinal flora of Guatemalan children . Am J Clin Nutr.1972;25:1380-1390.
34.
Long S.Botulism in infancy. PediatrDis.1984 ;3:266-271.
35.
Meyer KF, Dubovsky BJThe distribution of spores of B. botulinus in the United States. J Infect Dis.1922;31:559-594.
36.
Istre GR, Compton R., Novotny T., et al. Infant botulism: three cases in a small town. Am J Dis Child.1986; 140:1013-1014.
37.
L'Hommedieu CL, Polin RAProgression of clinical signs in severe infant botulism. Clin Pediatr (Phila).1980;20: 90-95.
38.
Waud BENeuromuscular Blocking Agents. In series: Current Problems in Anesthesia and Critical Care Medicine. Chicago, IL: Year Book Medical Publishers ; 1977;4:18.
39.
L'Hommedieu C., Stough R., Brown L., et al. Potentiation of neuromuscular weakness in infant botulism by aminoglycosides. J Pediatr.1979;95:1065-1070.
40.
Miller RDAntagonism of neuromuscular blockade. Anesthesiology . 1976; 44: 318-329.
41.
Waud BE, Waud DRThe margin of safety neuromuscular transmission in the muscle of the diaphragm . Anesthesiology.1972;37:417.
42.
Johnson R., Clay S., Arnon S.Diagnosis and management of infant botulism.
43.
Am J Dis Child.1979;133:586-593.
44.
Roland EH, Ebelt VJ, Anderson JD, Hill A.Infant botulism: a rare entity in Canada? Can Med Assoc J.1986; 135:130-131.
45.
Hatheway CLLaboratory procedures for cases of suspected infant botulism. Rev Infect Dis.1979;1:647-651.
46.
Hatheway CLPersonal communication, 1993.
47.
Martin R.Personal communication, 1993.
48.
Cornblath D. , Sladky J., Sumner A.Clinical electrophysiology of infantile botulism . Muscle Nerve. 1983 ;6:448-451.
49.
Graf WD, Hays RM, Astley SJ, Mendelman PMElectrodiagnosis reliability in the diagnosis of infant botulism. J Pediatr.1992;120:747-749.
50.
Frankovich TL, Arnon SSClinical trial of botulism immune globulin for infant botulism. West J Med.1991;154:103.
51.
Santos JI, Swenson P., Glasgow LAPotentiation of Clostridum botulinum toxin by aminoglycoside antibiotics: clinical and laboratory observations. Pediatrics. 1981;68:50-54.
52.
Glauser TA, Maguire HC, Sladky JTRelapse of infant botulism. Ann Neurol.1990 ;28:187-189.